Even if the combo trial results are soon shown to be positive and the Germans (Merck) then decide not as yet to buy us out, the SP will never thereafter fall below 1.00 $ even if we still have to wait months for the TLD and publication.
Reason: It will be clear that DCVax-L is working and that the trial most likely will be successful. The remaining painful waiting period for TLD+publication will be cushioned by an increased confidence of success, reflected by a higher SP.
Market Data 
Markets 
AI
